These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4401692)

  • 1. Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis.
    Sjaastad O; Stensrud P
    Acta Neurol Scand; 1972; 48(1):124-8. PubMed ID: 4401692
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of the use of a new beta-adrenergic blocker (LB 46) in angina pectoris.
    Aravanis C; Michaelides G
    Acta Cardiol; 1970; 25(5):501-9. PubMed ID: 4395273
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis.
    Ekbom K; Lundberg PO
    Headache; 1972 Apr; 12(1):15-7. PubMed ID: 4402287
    [No Abstract]   [Full Text] [Related]  

  • 4. LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias.
    Storstein L
    Acta Med Scand; 1972 May; 191(5):423-8. PubMed ID: 4402323
    [No Abstract]   [Full Text] [Related]  

  • 5. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
    Hickie JB
    Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977
    [No Abstract]   [Full Text] [Related]  

  • 6. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of lb 46, a new beta-adrenergic antagonist, in hyperthyroidism. Heart rate and blood pressure at rest and during exercise.
    Runeberg L; Kreus KE
    Acta Med Scand; 1971 May; 189(5):423-6. PubMed ID: 4397076
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current views on migraine and anti-migraine preparations].
    Ignatov IuD; Skoromets AA; Amelin AV
    Vestn Ross Akad Med Nauk; 2003; (10):13-9. PubMed ID: 14598505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled clinical trial of ergotamine tartrate.
    Waters WE
    Br Med J; 1970 May; 2(5705):325-7. PubMed ID: 4913961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strong and sustained-acting triptan. Therewith migraine does not return soon].
    MMW Fortschr Med; 2003 Aug; 145(31-32):53. PubMed ID: 14524078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial using the beta receptor blockader Visken].
    Szám I; Holló J
    Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind trial of LB-46 in the treatment of angina pectoris.
    Raychaudhuri B; Das MR; Neelakatan C; Chaudhuri ND; Bose J; Chetri MK
    Indian Heart J; 1973 Jan; 25(1):58-61. PubMed ID: 4576304
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of MY-25 (1-methyl-ergotamine-bitartrate) in migraine prophylaxis.
    Stensrud P; Skaug OE; Sjaastad O
    Headache; 1971 Oct; 11(3):128-31. PubMed ID: 4940168
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolfenamic acid is as effective as ergotamine during migraine attacks.
    Hakkarainen H; Vapaatalo H; Gothoni G; Parantainen J
    Lancet; 1979 Aug; 2(8138):326-8. PubMed ID: 89390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
    Poletti T; Aquaro G
    Minerva Cardioangiol; 1972; 20(7):402-18. PubMed ID: 4403233
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of tachycardial disturbances of the cardiac rhythm with a beta-adrenergic blocking agent (Visken)].
    Ley H; Ohlen J; von Richthofen W
    Munch Med Wochenschr; 1970 Nov; 112(48):2183-6. PubMed ID: 4098955
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with preparation LB-46 in various rhythm disorders and ischemic heart disease].
    De La Hoz Fabra J; Pérez Casar F; Carillo Kabana J
    Rev Esp Cardiol; 1970; 23(1):76-99. PubMed ID: 4393269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-receptor blockader LB 46 in the therapy of tachycardial arrhythmias].
    Novosel D
    Med Monatsschr; 1970 Oct; 24(10):466-71. PubMed ID: 4097485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta-blocking agents in angina pectoris. A double-blind trial].
    Aubert AB; Nyberg G; Slaastad R; Tjeldflaat L
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):409-13 passim. PubMed ID: 4393271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.